• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS CMV IGG ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS CMV IGG ASSAY Back to Search Results
Catalog Number 30204
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/13/2015
Event Type  malfunction  
Manufacturer Narrative
A sample of the patient's blood was received by biomerieux and was tested on retain samples from (b)(6).The sample tested positive for cmv igg on the retain sample.A review of the manufacturing batch records was performed and no nonconformances or anomalies were found.The sample was also tested with the following lots yielding the : (b)(6).A capa, (b)(4), has been initiated to further investigate the root cause of the discrepancies between lots.
 
Event Description
A customer contacted biomerieux regarding a discrepant result with the vidas cmv igg test.Vidas cmv igg is an automated quantitative enzyme immunoassay for use on the vidas family instruments for the quantitative measurement, of anti-cytomegalovirus igg (cmvg) in human serum, using the elfa (enzyme linked fluorescent assay) technique.The test is positive if the value is >= 6 ua/ml.A patient sample was tested on (b)(6) 2015 using the vidas cmv igg test and the result was positive at 9 ua/ml.Another chemioluminescence method gave a negative result (<0.150 ui/ml for a threshold of 0.5 ui/ml).A new sample of the same patient was tested on (b)(6) 2015 using the same lot and the result was still positive at 10 ua/ml.Another chemiluminescence method gave a negative result (<0.150 ui/ml for a threshold of 0.5 ui/ml).The result of the antibodies igm was negative with two techniques.
 
Manufacturer Narrative
The patient sample collected on (b)(6)-2015 was sent to biomérieux to be tested.The (b)(6) result was reproduced on lot 1003035170 used by the customer.The sample was also tested with the additional lots and the results obtained are summarized below: (b)(6).A review of the manufacturing record was performed and no anomalies or abnormal incidents were noted to have occurred during manufacturing of this lot.As the lot is expired, no additional investigations can be performed.There is no corrective or preventive actions associated to the reported complaint because there is no evidence of a sensitivity issue or product malfunction with the referenced lot 1003035170.The root cause of the discrepant positive results obtained by the customer could not be determined although it could not rule out a sample related effect.In mitigation of the discrepant positive results obtained by the customer, vidas cmvg instruction for use - limitation of the method - reads: 1) the vidas cmvg assay results should be interpreted taking into account the clinical symptoms and the medical analysis results from other tests (e.G.Detection of anti-cmv igm in case of primary infection).2) interference may be encountered with certain sera containing antibodies directed against reagent components.For this reason, assay results should be interpreted taking into consideration the patient history, and the results of any other tests performed.There is no indication that lot 1003035170 was outside performance expectations; therefore, no further action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS CMV IGG ASSAY
Type of Device
VIDAS CMV IGG ASSAY
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 6928 0
FR   69280
Manufacturer Contact
ryan lemelle
595 anglum road
hazelwood, MO 63042
3147318582
MDR Report Key4851454
MDR Text Key22952079
Report Number3002769706-2015-00048
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K920661
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/16/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/17/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/23/2015
Device Catalogue Number30204
Device Lot Number1003283600
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/16/2015
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-